Pharmaceutical group · Italy
Chiesi
A group of 13 companies with 305 medicines in 10 countries.
Group structure
13 companies in 10 countries
United States2
Austria1
Brazil1
Canada1
4 more countries
France1
Netherlands1
Saudi Arabia1
United Kingdom1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 305
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALERFIN | Beclometasone | Brazil | Authorised | 2003 |
| APOFINSoluzione iniettabile in penna pre-riempita | Apomorphine | Italy | Authorised | |
| ARTEDIL 10 mg COMPRIMIDOS10 mg · Comprimido | Manidipino | Spain | Marketed | 2002 |
| ARTEDIL 20 mg COMPRIMIDOS20 mg · Comprimido | Manidipino | Spain | Marketed | 2020 |
| ARTEDIL 20 MG COMPRIMIDOS20 mg · Comprimido | Manidipino | Spain | Marketed | 2023 |
| ARTEDIL 20 mg COMPRIMIDOS20 mg · Comprimido | Manidipino | Spain | Marketed | 2020 |
| ARTEDIL 20 MG COMPRIMIDOS20 mg · Comprimido | Manidipino | Spain | Marketed | 2024 |
| ARTEDIL 20 mg COMPRIMIDOS20 mg · Comprimido | Manidipino | Spain | Marketed | 2002 |
| ASALEXCompressa a rilascio modificato | Mesalazine | Italy | Authorised | |
| ATIMOSSoluzione pressurizzata per inalazione | Formoterol | Italy | Authorised | |
| Atimos 12 microgram, Aërosol, oplossingAërosol, oplossing | Formoterol | Netherlands | Authorised | 2007 |
| AUXINA A+E FUERTE CÁPSULAS BLANDAS50 kilo UI + 100 mg · Cápsula blanda | Vitamin a, Vitamin e | Spain | Marketed | 1960 |
| AUXINA A MASIVA 50.000 UI CAPSULAS BLANDAS50 kilo UI · Cápsula dura | Vitamin a | Spain | Marketed | 1958 |
| AUXINA E-200 UI CAPSULAS BLANDAS206,000 mg · Cápsula blanda | Todo-alfa-tocoferol | Spain | Marketed | 1960 |
| AUXINA E-400 UI CAPSULAS BLANDAS400 mg · Cápsula blanda | Todo-rac-alfa-tocoferilo | Spain | Marketed | 1998 |
| AUXINA E-50 UI CAPSULAS BLANDAS51,500 mg · Cápsula blanda | Todo-alfa-tocoferol | Spain | Marketed | 1950 |
| BAMIFIX | Bamifilina | Brazil | Authorised | 2000 |
| BETHKIS300mg/4ml · Solution | Tobramycin | United States | Marketed | 2012 |
| BRAMITOBSoluzione per nebulizzatore | Tobramycin | Italy | Authorised | |
| BRAMITOB | Tobramycin | Brazil | Authorised | 2009 |
| Bramitob 300 mg/4 ml otopina za nebulizatorotopina za nebulizator | Tobramycin | Croatia | Marketed | 2019 |
| BRAMITOB 300 mg/4 ml SOLUCION PARA INHALACION POR NEBULIZADOR300 mg · Solución para inhalación por nebulizador | Tobramycin | Spain | Marketed | 2007 |
| Bramitob, verneveloplossing 300 mg/4 mlVerneveloplossing | Tobramycin | Netherlands | Authorised | 2007 |
| BRONCHO-VAXOM | Lisado bacteriano | Brazil | Authorised | 2021 |
| BRONCORAL NEO 12 microgramos/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION0,012 mg · Solución para inhalación por nebulizador | Formoterol | Spain | Marketed | 2005 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 76 | 69 | 7 | CompaniesAll medicines |
| Brazil | 61 | 25 | 36 | CompaniesAll medicines |
| Italy | 41 | 41 | 0 | CompaniesAll medicines |
| Netherlands | 37 | 37 | 0 | CompaniesAll medicines |
| United States | 25 | 25 | 0 | CompaniesAll medicines |
| Canada | 19 | 18 | 1 | CompaniesAll medicines |
| European Union (EMA) | 15 | 14 | 1 | CompaniesAll medicines |
| Romania | 15 | 0 | 15 | CompaniesAll medicines |
| Saudi Arabia | 10 | 10 | 0 | CompaniesAll medicines |
| Croatia | 6 | 6 | 0 | CompaniesAll medicines |
Also in the registers of France, Serbia, Singapore, United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Drugs for obstructive airway diseasesRespiratory system · ATC R03A
- Other alimentary tract and metabolism productsAlimentary tract and metabolism · ATC A16A
- Lipid-modifying agentsCardiovascular system · ATC C10A
- Other respiratory system productsRespiratory system · ATC R07A
- ImmunosuppressantsAntineoplastic and immunomodulating agents · ATC L04A
Top substances
The active substances in most of its medicines.
- Beclometasone63 medicines
- Formoterol48 medicines
- Deferiprone15 medicines
- Lomitapide15 medicines
- Glycopyrronium12 medicines
- Metreleptin11 medicines
- Mercaptamine10 medicines
- Manidipino9 medicines
- Tacrolimus9 medicines
- Pegunigalsidase alfa7 medicines
- Natural phospholipids7 medicines
- Caffeine7 medicines
- Cangrelor7 medicines
- Nicardipine7 medicines
- Velmanase alfa6 medicines
- Tobramycin6 medicines
- Budesonide5 medicines
- Delapril5 medicines
- Glycopyrroniumbromide5 medicines
- Clevidipine5 medicines
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- chiesi canada
- chiesi espana
- chiesi farmaceuticis
- chiesi hellas
- chiesi italia
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
All 32 sources
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA; Gazzetta Ufficiale della Repubblica Italiana. Exact act IDs, publication dates, locators, URLs and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: Official administrative act text exclusion, Italian Law633/1941 Article5
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.